Because of the conflicting reports on the effect of non-insulin-dependent diabetes on UCP3 expression in the heart, we first set out to quantify cardiac UCP3 levels in a panel of rodent models of obesity, insulin resistance and type 2 diabetes. The gene discussed is UCP3; the disease is obesity due to melanocortin 4 receptor deficiency.